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Multilineage donor-derived hematopoietic cell 
chimerism is a persistent feature of spontaneously 
tolerant mouse liver allograft recipients. We have 
shown previously that normal liver-derived precur-
sors of "chimeric" dendritic cells (DC) propagated in 
vitro migrate in vivo to T-dependent areas of alloge-
neic lymphoid tissue, where they or their progeny 
appear to persist indefinitely. In this study, granu-
locyte-macrophage colony-stimulating factor (GM-
CSF)+interleukin-4 (lL-4) were used to propagate 
DC progenitors from freshly isolated mouse bone 
marrow. The progenitor cells gave rise in 7-10 days 
to potent antigen-presenting cells (APC) that stimu-
lated naive allogeneic T cells in primary mixed leu-
kocyte cultures (MLC). The culture method, together 
with the reverse transcriptase-polymerase chain re-
action (RT-PCR) for the detection of donor and re-
cipient strain major histocompatibility complex 
(MHC) class II mRNA was used to test whether do-
nor-derived DC could be propagated from the bone 
marrow of unmodified, orthotopic liver allograft reo 
cipients. Freshly isolated bone marrow from these 
transplanted animals contained small numbers of do· 
nor cells and responded to GM-CSF+ IL-4 stimulation. 
In addition to cells expressing recipient (BI0) pheno· 
type (H-2Kb +; lab +), a minor population of donor 
(BIO.BR)·derived cells (H.2Kk +; lak ) were also propa· 
gated from liver graft recipients euthanized two 
weeks posttransplant. DC sorted from these cultures 
exhibited stimulatory activity for recipient strain T 
cells consistent with a low level «1%) of donor DC 
propagation. The immunologic role of donor-derived 
DC progenitors in liver allograft recipients and its 
relation to the induction and maintenance of donor· 
specific unresponsiveness remains to be determined. 
It has been postulated that the reduced immunogenicity of 
orthotopic liver allografts compared with those of other solid 
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organs may be a consequence of the migration and perpetu-
ation within host lymphoid tissues of potentially tolerogenic, 
donor-derived ("chimeric") leukocytes, in particular the pre-
cursors of chimeric DC* (1). In animals and in man, intersti· 
tial DC, such as those seen in normal liver, are believed to 
arise from proliferating bone marrow-derived precursors (2), 
that can be induced to proliferate in vitro in response to 
GM-CSF (3). In this study, we present cellular and molecular 
evidence that mouse liver allografts export DC precursors 
that can be detected in the bone marrow of nonimmunosup-
pressed recipients. These cells can be induced to proliferate 
and mature into potent APC in response to GM-CSF+ IL-4. 
This observation is congruent with the possibility that donor 
hematopoietic cell chimerism may play a key role in liver 
allograft acceptance and acquired transplantation tolerance. 
MATERIALS AND METHODS 
Animals. Male B10.BR (H-2k , I·E+) and C57BU10 SnJ (BI0, 
H_2b, I-E-) mice 10-12 weeks old were purchased from The Jackson 
Laboratory, Bar Harbor, ME. Orthotopic liver transplantation 
(OLTx) was performed from BIO.BR donors to BIO recipients as 
described previously (4), with minor modifications. No immunosup-
pressive therapy was used. The animals (three per group in each 
experiment) were euthanized 14 days after OLTx. Before harvesting 
of tissue from transplanted animals, whole body perfusion was per-
formed (5) to minimize blood contamination. Pooled bone marrow cell 
suspensions were prepared in RPMI-1640 (Gibco, Grand Island, NY) 
using conventional methods. 
Culture of bone marrow·derived cells with GM-CSF+ IL-4. Cells 
(2-5XI06 ) in 2 ml RPMI-1640 complete medium supplemented with 
10% vlv heat-inactivated fetal bovine serum (FBS; Gibco), GM-CSF 
(4 ng/ml) and IL-4 (1000 U/ml) (each cytokine from Schering-Plough, 
Kenilworth, NJ) were cultured per well in 24-well plates. The pro-
cedure for propagation of DC from mouse bone marrow was similar 
to that described by Inaba et a1. (3) with minor modifications (5). IL-4 
was added to promote growth of DC and to maximize the develop-
ment of potent APC function (6). The cytokine-containing medium 
was refreshed every two days. Morphological, phenotypic and func-
tional analyses of typical, single, non-adherent mononuclear cells 
were performed after 8-10 days. 
Staining of cell surface antigens. Cell surface antigens were ana-
lyzed by immunofluorescence staining and cytofluorography on a 
FACScan (Becton Dickinson & Co., Mountain View, CAl as described 
* Abbreviations: APC, antigen-presenting cell; DC, dendritic cell; 
GM-CSF, granulocyte-macrophage colony-stimulating factor; IL-4, 
interleukin-4; mAb, monoclonal antibody; MHC, major histocompat· 
ibility complex; MLC, mixed leukocyte culture; PCR, polymerase 
chain reaction; RT, reverse transcriptase; OLTx, orthotopic liver 
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(5, 7). Donor and recipient MHC class I and class II positive cells 
were identified using biotin-conjugated mouse anti-mouse monoclo-
nal antibodies (mAbs) (PharMingen, San Diego, CAl with FITC 
streptavidin (Jackson Immunoresearch Lab. Inc., West Grove, PAl 
as the secondary reagent. Appropriate rat, hamster or mouse immu-
noglobulin isotype controls were performed in each experiment. 
Background staining was uniform between samples. 
Detection of donor and recipient MHC class II mRNA in cell 
cultures by RT-PCR analysis. Total RNA was prepared from either 
freshly isolated or cultured bone marrow cells by standard methods 
using RNAzol B (Biotecx, Houston, TX) (8). RNA concentrations were 
determined by measuring the absorbance at 260 nm. eDNA was 
synthesized by using 3 /Lg of total RNA template with Moloney 
murine leukemia virus reverse transcriptase (RT) (Life Technolo-
gies) and Oligo dT primer in a final volume of 10 p.l. Using 300 ng 
of this first-strand eDNA as template, PCR amplification was 
conducted for 30 cycles (94°CX1 min, 59°Cx1 min, 72°C x 1 min) 
with Taq DNA polymerase and a model 480 Thermal Cycler (both 
from Perkin-Elmer, Norwalk, CT) using oligonucleotide amplimers 
targeted to the coding region sequences of eDNA for lab and Iak (9, 
10). These primers were 20 nucleotides long with the following se-
quences: 
lab forward-5' AGTTTGGCCAATTGGCAAGC3' 
Iak forward-5' AGTTTGCTCAACTGAGAAGA3' 
Ia reverse-5'CCACCTTGCAGTCATAAATG3' 
The predicted PCR products span from 198 to 554 bp for lab and 
from 244 to 600 bp for Iak to yield the same predicted PCR product 
size of 356 bp. Ethidium bromide-stained 2% agarose gels were used 
to analyze the PCR products. RT-PCR for /3-actin served as a control 
for eDNA synthesis. 
Sorting of dendritic cells. Before staining with mAb, the cultured 
bone marrow-derived cells were incubated with 10% v/v normal goat 
serum (Vector, Burlingame, CAl in Hanks balanced salts solution 
(HBSS) (Gibco) at 4°C for 30 min to eliminate nonspecific binding. 
The cells were then washed once in HBSS containing 0.1% v/v bovine 
serum albumin (Sigma) and resuspended at 40X 106/ml in the same 
buffer. A saturating concentration of the mouse DC restricted mAb 
log fluorescence intensity 
FIGURE 1. The expression of selected cell surface immunophenotypic 
markers on GM-CSF+IL-4-stimulated mouse (B10.BRl bone mar-
row-derived DC 10 days after the initiation of cultures. Un shaded 
profiles denote appropriate immunoglobulin isotype controls. The 
results are representative of 3 separate experiments. 
NLDC-145 (a gift from Dr. R. M. Steinman, The Rockefeller Univer-
sity, New York, NY) or rat IgG2a isotype control (Sigma) was added 
and the cells incubated for 45 min at 4 DC. After two washes in HBSS, 
the cells were stained with FITC-conjugated goat anti-rat IgG 
(Sigma) under the same conditions. They were then washed and 
resuspended in complete RPMI-1640 media supplemented with 2% 
v/v FBS for sorting. NLDC-145+ and NLDC-145- cells were sorted 
into distinct cell populations based on forward scatter, side scatter, 
and FITC fluorescence intensity using a FACStarPlus cell sorter 
(Becton Dickinson). Purities of both populations >90% were at-
tained. 
Mixed leukocyte cultures (MLC). Three day, one-way MLC (2x 105 
responder T cells per well in 96-well, round-bottomed microculture 
plates) were performed as described (5). Cells were cultured in 
RPMI-1640 supplemented with 10% heat-inactivated FBS in 5% CO2 
in air. Various numbers of y-irradiated (20 Gy) stimulator cells 
propagated with GM-CSF+ IL-4 from donor (BlO.BR) or recipient 
(B10) strain animals or from the bone marrow of liver allograft 
recipients were added. To assist in determining the incidence of 
donor-derived allostimulatory cells propagated from graft recipients, 
"artificial" mixtures of cultured donor (1-10%), and recipient strain 
bone marrow-derived cells were also used as stimulators. Normal 
B10 or BlO.BR splenic T cells served as responders. [3H]TdR (1 ,!LCi) 
was added to each well, 18 hr before harvesting onto glass fiber disks 
using a multiple cell harvester. eH]TdR uptake was determined 
using a liquid scintillation counter. Each measurement was per-
formed in triplicate and data presented as mean counts per minute 
(cpm):t lSD. 
RESULTS 
Immunophenotypic analysis of bone marrow-derived DC. 
Flow cytometric analysis of lO-day cultured bone marrow-
derived cells was performed after either direct or indirect 
immunofluorescence staining using an extensive panel of 
mAbs as described (5). Staining for cells of lymphoid lineage 
(CD3+, CD4+, CD8+, B220+, and NK1.1+) was absent. The 
cells expressed CD45 (leukocyte-common antigen), MHC 
class I, heat-stable antigen (JllD), CD54 (intercellular ad-
hesion molecule-I), CDllb (MAC-I), CD44 (nonpolymeric de-
terminant of Pgp.l glycoprotein), and the mouse DC-re-
stricted markers NLDC-145 (interdigitating cells), 33Dl and 
CDllc (N418; f32-integrin). The macrophage antigen F4/80 
and FcyRII (CD32) were also expressed as described previ-
ously for GM-CSF-stimulated mouse bone marrow-derived 
DC (3). In addition, the cells exhibited high levels of MHC 
class II, and low and moderate levels, respectively, of the 
costimulatory molecules B7-1 and B7-2. A restricted immu-
nophenotypic profile of these cells depicting DC characteris-
tics is shown in Figure 1. 
Detection of cells expressing donor phenotype in freshly 
isolated and GM-CSF+IL-4-stimulated bone marrow from 
liver allograft recipients. To identify cells expressing donor 
phenotype in freshly isolated bone marrow from nonimmu-
nosuppressed BID mice 14 days after OLTx from BIO.BR 
donors, mAbs directed against donor (H-2Kk) and recipient 
(H-2Kb ) MHC class I antigens were used. In addition, prim-
ers specific for donor or recipient MHC class II were used to 
detect mRNA transcripts by RT-PCR. In allografted mice, the 
incidence of freshly isolated bone marrow cells expressing 
donor MHC class I determined by flow cytometry was very 
low (approx. 1%). That of the recipient was. as expected. 
consistently very high (>84%). RT-PCR analysis of MHC 
class II mRNA expression in freshly-isolated bone marrow 
also revealed the presence of donor cells (Fig. 2), 
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FreshBM 
Cultured DC 
FIGURE 2. Demonstration of mRNA for donor (Iak) and recipient 
strain (lab) MHC class II by RT·PCR analysis. RNA was isolated 
either from fresh bone marrow (BM) (upper panel) or from lO·day 
bone marrow-derived DC propagated in GM-CSF+ IL-4 as described 
in Materials and Methods (lower panel). (1) Normal BlO (H-2b ); (2) 
Normal BlO.BR (H-2k); (3) Liver (BlO.BR)·allografted BlO; (4) Nor· 
mal BlO; (5) Normal BlO.BR; (6) Liver (BI0.BR)·allografted BI0. 
We next determined whether DC expressing donor pheno-
type could be propagated from postulated small numbers of 
donor·derived progenitor cells in the freshly isolated bone 
marrow of unmodified liver allograft recipients. In several 
repeat experiments, both cells expressing recipient MHC 
class I (H-2Kb +) and a minor population expressing donor 
MHC class I (H-2Kk +) could be identified by cytofluorimetry 
in the lO·day DC cultures. The cell population was in the 
correct area for DC as identified by labeling with a specific 
marker (NLDC·145) and forward and side scatter profiles. 
Detection of mRNA for donor MHC class II (lak ) confirmed 
the presence of donor-derived cells in the lO·day DC cultures 
(Fig. 2) propagated from the bone marrow of the transplant 
recipients. 
Allostimulatory activity of donor·derived DC. NLDC-I45 + 
cells were sorted to at least 90% purity by morphologic and 
F ACScan analysis, and then investigated for their capacity to 
induce a primary MLR. As shown in Table 1, the purified 
NLDC-I45+ population propagated from BIO recipients of 
BIO.BR allografts strongly stimulated BlO.BR responders, 
but also stimulated a much more modest response in recipi-
ent strain BlO T cells (Table 2). The extent of stimulation 
(P<O.OI compared with negatively sorted cells or syngeneic 
DC) was similar to that achieved with "artificial mixtures" of 
GM-CSF+ IL-4 stimulated cells containing 1% donor strain 
and 99% recipient strain DC (Table 2), 
DISCUSSION 
We have previously demonstrated myeloid progenitors in 
normal mouse liver, using similar methods to those used in 
the present study (5), Thus, DC progenitors were propagated 
from normal liver nonparenchymal cells in response to GM-
CSF (5). Following their local or systemic injection into un· 
modified MHC and non-MHC disparate recipients, these 
cells homed to T cell areas of the host's lymphoid tissues (11), 
where at least some could be detected by cell surface expres-
sion of donor MHC class II. These observations suggested a 
possible basis for the establishment and perpetuation of do-
nor-derived cell (DC) microchimerism after OLTx. In the 
present study, an MHC class 1 and II-disparate mouse strain 
combination EBflIBo~BllF that accepts liver grafts sponta-
neously was used to determine whether liver·derived DC 
progenitors could be propagated from recipient lymphoid tis-
sue. 
The presence of donor and recipient MHC class 1+ leuko-
cytes, and of cells expressing message for donor or recipient 
MHC class II was investigated in freshly isolated bone mar-
row cell suspensions 14 days after OLTx. As anticipated, 
donor class 1+ cells were rare (about 1%) in the freshly 
isolated cell populations. When cells were harvested from 
recipient bone marrow 14 days after OLTx, then cultured for 
10 days in GM·CSF+ IL-4, a significant proportion of the 
TABLE 1. Allostimulatory activity of sorted GM·CSF+ IL-4 stimulated bone marrow-derived DC for donor strain (BI0,BRl T cellsa 
Stimulators (X 103) 
Recipient strain: BI0 DC 
12.5 
25.0 
Donor strain: BI0.BR DC 
12.5 
25.0 
Artificial mixture: 
BlO,BR+I0% BI0 DC 
12.5 
25.0 
Allograft recipient <BI0): 
BlO.BR .... BI0<OLTxl DC 
12.5 
25.0 
S:Rb cell ratio 
1:16 
1:8 
1:160 
1:80 
Unknown 
Unknown 
cpm:!: 1SD (X 103) Stimulation index 
102.04:!:5,62 8.6 
95.22:!:9.69 9.8 
11.8l:!:1.07 1.0 
15.63:!: 1.27 1.0 
45.04:!:4.12 3,8 
50.73:!:0.54 1.9 
83,89:!:5.23 7,1 
103,21:!:10.61 6,6 
a The stimulator cells were harvested from lO-day cultures and set up in 72-hr MLC with 2x 105 responder T cells, Syngeneic or allogeneic 
cells, artificial mixtures of syngeneic and allogeneic cells, or cells propagated from the bone marrow of liver allograft recipients were tested 
as stimulators. Fresh syngeneic spleen cells (50x 103 ) (BlO.BR) did not induce an MLR. The results are representative of 3 separate 
experiments. 
b Stimulator: responder. 
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TABLE 2. Allostimulatory activity of sorted GM-CSF+ IL-4-stimulated bone marrow-derived DC for recipient strain (B10) T cellsa 
Stimulators (x 103 ) S:R cell ratio cpm:tlSD (X103 ) Stimulation index 
Recipient strain (B10) DC: 
12.5 
25.0 
Donor strain (B10.BR) DC: 
12.5 
25.0 
Artificial mixture 
B10+ 10% BlO.BR DC 
12.5 
25.0 
B10+5% BlO.BR DC 
12.5 
25.0 
BlO+ 1 % B10.BR DC 
12.5 
25.0 
1:16 
1:8 
1:160 
1:80 
1:320 
1:160 
1:1600 
1:800 
10.72±2.15 
14.08±1.93 
107.47±7.84 
121.17±9.54 
45.47±11.52 
43.08±2.73 
37.78±7.14 
45.77±8.09 
27.33±0.80 
32.05±5.55 
1.0 
1.0 
10.0 
8.6 
4.2 
3.1 
3.5 
3.3 
2.5 
2.3 
Allograft recipient (B10) 
B10.BR-B10(OLTx) DC 
12.5 
25.0 
Unknown 
Unknown 
19.66±5.23 1.8 
23.24±1.73 1.7 
a The stimulator cells were harvested from lO-day cultures and set up in 72-hr MLC with 2 X 105 responder T cells. Syngeneic or allogeneic 
cells, artificial mixtures of syngeneic and allogeneic cells, or cells propagated from the bone marrow of liver allograft recipients were tested 
as stimulators. Fresh syngeneic spleen cells 50X 103 (B10) did not induce an MLR. The results are representative of 3 separate experiments. 
developing DC exhibited donor phenotype. Further evidence 
for donor-derived DC in cell cultures from allograft recipients 
was obtained by demonstration of allostimulatory activity for 
naive recipient strain T cells, using highly purified NLDC-
145+ cell populations. The extent of stimulation was similar 
to that achieved with an "artificial mixture" containing 1% 
donor strain DC. This suggests that a similar proportion of 
donor cells were present in the cultured bone marrow popu-
lation from liver allograft recipients. There may however, be 
strain differences in growth of donor versus host bone mar-
row progenitors. To account for this, and to obtain a clearer 
indication of the growth potential of donor cells in the pres-
ence of recipient progenitors, it will be necessary in future 
experiments to propagate mixed populations of donor and 
host bone marrow cells in different compositions prior to 
sorting and testing in the MLR. In a separate study, using a 
different mouse strain combination EBfM~CPe; e_Ob~ 
H-2k), we have demonstrated propagation of male donor-
derived DC bearing the Y chromosome from progenitors in 
the bone marrow of unmodified female liver allograft recipi-
ents (12). 
Our observations appear to explain the persistence of low 
level hematopoietic cell chimerism in the mouse orthotopic 
liver transplant model in the absence of host immunosup-
pression. They are also consistent with the adult liver con-
taining comparatively large numbers of (potential migratory) 
hemopoietic cells (13), including DC progenitors, with the 
capacity to propagate ex vivo in response to appropriate 
cytokine growth factors. The observation that organ trans-
plantation permits the growth of donor as well as recipient 
progenitor DC is congruent with the paradigm of bidirec-
tional immune reactivity-which, as we have suggested, may 
explain whole organ graft acceptance and acquired trans-
plantation tolerance (1,14,15). It appears that the recipients' 
tissues become repositories of precursor cells of myeloid and 
probably other lineages, or perhaps even of pluripotent stem 
cells. As in this study, the presence of these precursor cells 
can potentially be identified by their patterns of differentia-
tion under the influence of appropriate cytokines. 
The functional role of the precursors of chimeric DC is 
currently being investigated. There is strong evidence that 
the reduction of MHC class I-specific cytotoxic responses in 
mice injected with allogeneic donor lymphoid cells is a func-
tion of donor deletional APC that inactivate MHC class 1-
reactive cytotoxic T cell precursors that recognize them (16l. 
Others have demonstrated a veto function for subpopulations 
of mouse DC (17) or putative "immature" DC in primate 
allogeneic bone marrow (18). Furthermore, DC within cer-
tain tissues such as the anterior chamber of the eye (9) or 
thymus (20) appear to have the capacity to induce antigen-
specific tolerance in adult animals. 
The presence of donor-derived DC for up to 1 year in 
rodents tolerant to their hepatic allografts (21) and for many 
years after OLTx in humans (22) has been demonstrated. 
The magnitude, tissue-specific site dependency, replicative 
capacity, or maturational stage of chimeric DC (including cell 
surface expression of key T cell costimulatory molecules r23]) 
that may be necessary to mediate postulated tolerizing ef· 
fects of these cells has not been established. However, cul-
tured bone marrow-derived DC that are deficient in cell-
surface expression of costimulatory (B7) molecules can 
induce alloantigen-specific anergy in allogeneic T cells in 
vitro (24). Moreover, these bone marrow-derived cells and 
DC progenitors propagated from mouse liver can signifi-
cantly prolong the survival of heart (25) and pancreatic islet 
allografts (26), respectively_ Conceivably, following liver 
transplantation, the recipient bone marrow may provide a 
repository of donor-derived DC progenitors with the potential 
to migrate to central or peripheral lymphoid tissue sites and 
therein to affect the responsiveness of host alloantigen-spe-
cific T cells. The observations in this study provide an oppor-
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tunity for elucidation of the role of these donor-derived cells 
in the induction and maintenance of donor-specific unrespon-
siveness following organ transplantation. 
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